Published Jul 21, 2015
Manila, the Philippines - There is a high prevalence and high economic burden of community-acquired pneumonia in the Philippines. At present, the Philippine Health Insurance Corporation (PhilHealth) coverage for Community-acquired Pneumonia-Moderate Risk (CAP-MR) and Community-acquired Pneumonia-High Risk (CAP-HR) are PHP 15,000 (US$354) and PHP32,000 (US$754), respectively. As described in the article, “Economic Burden of Community-Acquired Pneumonia among Adults in the Philippines: Its Equity and Policy Implications in the Case Rate Payments of the Philippine Health Insurance Corporation,”  published in Value in Health Regional Issues Volume 6 focusing on Asia, the study was conducted in two tertiary hospitals, one in Manila, the capital of the Philippines and the other one located in a suburban area, about 30 kilometers south of Manila, estimated cost of hospitalization for CAP-MR and CAP-HR in 2012 were PHP 24,400 – 89,400 (US$575 – $2,100) and PHP 92,800 – 213,400 (US$2,190 – $5,030), respectively. The objectives of the study were:  1) to determine the cost of hospitalization and 1-week after hospitalization for pneumonia; 2) the difference between the estimated costs and PhilHealth pneumonia case rate payments; and 3) the economic burden of community-acquired pneumonia among patients age 19 years and older in the Philippines. Based on the study results for the cost of hospitalization for pneumonia and PhilHealth claims for 2012, the cost for hospitalization for community-acquired pneumonia for CAP-MR and CAP-HR were PHP 8.48 billion and 643.76 million, respectively. Apart from significantly higher from those calculated based on the PhilHealth case rate payments, these figures more accurately reflect the true economic burden of hospitalization for pneumonia in the Philippines. “The study results are notably disparate from the present PhilHealth case rate payments, thus the corresponding difference between the two needs to be shouldered either by the patient or the patient’s relative or by the government hospital in the case of indigent patients.  This has both equity and economic implications which are discussed in the study.” the presenting author, Bernadette A. Tumanan-Mendoza, MD, MScCE, MHE, Consultant, Department of Internal Medicine, Manila Doctors Hospital and a faculty member of the Department of Clinical Epidemiology of the University of the Philippines Manila College of Medicine, quoted.

Related Stories

Value in Health Regional Issues Expands Editorial Scope and Reveals Plans to Transition to Gold Open Access Model

Jan 23, 2024

Value in Health Regional Issues, an official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Empowering Change: Transforming Health Systems in Low- and Middle-Income Countries

Jan 22, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries through partnerships between health economics researchers and policy makers.

ISPOR’s Value in Health Regional Issues Receives Its First Impact Factor Score

Aug 7, 2023

Value in Health Regional Issues, the regionally focused journal of ISPOR, received its first-ever impact factor score this year. Value in Health, one of the top-ranked journals in the HEOR field, maintained its high ranking on the prestigious list of scholarly journals.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now